An Ohio woman on Tuesday filed a proposed class action lawsuit against Mylan Pharmaceuticals Inc (MYL.O) in an Ohio county court, claiming sharp price hikes for the company's EpiPen device violated the state's consumer protection law.
Mylan has raised the U.S. price of EpiPen, which is used to treat life-threatening allergies, from less than $100 when it acquired the product in 2007 to more than $600, drawing criticism from parents, consumer groups and U.S. politicians.
EpiPens automatically inject a dose of the drug epinephrine into the thigh to counter dangerous reactions to allergens such as peanuts, foods and bee stings. It has a 94 percent share of the market for such auto-injector devices.
A Mylan spokeswoman, Nina Devlin, had no immediate comment.
The company has defended EpiPen's high price, saying it spent hundreds of millions of dollars to improve the product. It has also said it recoups less than half the list price for EpiPens.
Tuesday's lawsuit was filed in the Court of Common Pleas for Hamilton County, Ohio, by Cincinnati resident Linda Bates, whose son requires an EpiPen.
The outrageous, unconscionable and immoral high prices set by Defendant is nothing more than price gouging, the complaint says.
It says the price increases violated ...